drugset / Trial / NCT04568772

Study to Evaluate the Influence of Tegoprazan on the Pharmacokinetics of Proguanil in Healthy Volunteers

NCT04568772

Phase 1 Completed 19 enrolled Seoul National University Hospital
RandomizedCrossoverOpen-labelOther

Summary

The aim of this study is to evaluate the influence of tegoprazan on the pharmacokinetics of proguanil in healthy volunteers.

Timeline

Start
2020-11-25
Primary completion
2021-07-08
Completion
2021-08-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 40 mg Oral
Subject Proguanil Small molecule 100 mg Oral
Subject Tegoprazan Other / unclassified 50 mg Oral
Subject Vonoprazan Other / unclassified 20 mg Oral
Background Atovaquone Small molecule 250 mg Oral